X0708 D LIVE 0001671502 Quoin Pharmaceuticals, Ltd. 42127 PLEASANT FOREST COURT ASHBURN VA VIRGINIA 20148-7349 (703) 980-4182 ISRAEL None Cellect Biotechnology Ltd. Cellect Biomed Ltd. Corporation true Michael Myers 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Executive Officer Director Sally Bridget Lawlor 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Executive Officer Denise Carter 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Executive Officer Director Joseph Cooper 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director James Culverwell 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Dennis Langer 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Natalie Leong 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Michael Sember 42127 Pleasant Forest Court Ashburn VA VIRGINIA 20148 Director Pharmaceuticals Decline to Disclose 06b false 2025-10-14 false true true false 0 Maxim Group LLC 000120708 None None 300 PARK AVENUE 16th Floor New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT DE DELAWARE KY KENTUCKY MD MARYLAND NV NEVADA NJ NEW JERSEY NY NEW YORK TX TEXAS true 105254891 105254891 0 The total offering amount reflects the total gross proceeds to be received assuming cash exercise of all warrants issued in the private placement. false 27 1227995 true 0 Estimated commissions and fees paid at closing include cash fee of 7% of aggregate gross proceeds of private placement (except no cash fee paid for securities purchased by a Company director) and up to $75,000 for legal and other out-of-pocket expenses. 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers false Quoin Pharmaceuticals, Ltd. /s/ Dr. Michael Myers Dr. Michael Myers Chief Executive Officer 2025-10-23